Giro C, Yamada AMTD, Cruz FJSM, do R Barros LA, et al. Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study. Breast Cancer Res Treat 2024 May 14. doi: 10.1007/s10549-024-07366.
PMID: 38743176